Boundless Bio, Inc. Common Stock (BOLD)
USD 1.28
(-7.25%)
USD 1.28
(-7.25%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 256.97 Million USD | 62.1% |
| 2022 | 158.52 Million USD | 4.36% |
| 2021 | 151.9 Million USD | 0.0% |
| 2018 | 29.8 Million USD | 35.07% |
| 2017 | 22.06 Million USD | -2.74% |
| 2016 | 22.68 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 10.64 Million USD | -95.86% |
| 2024 Q2 | 8.95 Million USD | -15.85% |
| 2023 Q2 | 258.79 Million USD | 0.0% |
| 2023 Q4 | 256.97 Million USD | -1.08% |
| 2023 Q3 | 259.78 Million USD | 0.38% |
| 2023 FY | 256.97 Million USD | 62.1% |
| 2022 Q4 | 158.52 Million USD | 0.0% |
| 2022 FY | 158.52 Million USD | 4.36% |
| 2021 FY | 151.9 Million USD | 0.0% |
| 2019 Q1 | 53.18 Million USD | 78.45% |
| 2019 Q3 | 58.04 Million USD | -0.62% |
| 2019 Q2 | 58.41 Million USD | 9.84% |
| 2018 Q4 | 29.8 Million USD | 9.49% |
| 2018 Q3 | 27.21 Million USD | 8.49% |
| 2018 Q2 | 25.08 Million USD | 21.5% |
| 2018 Q1 | 20.64 Million USD | -6.42% |
| 2018 FY | 29.8 Million USD | 35.07% |
| 2017 Q1 | 19.21 Million USD | -15.32% |
| 2017 FY | 22.06 Million USD | -2.74% |
| 2017 Q4 | 22.06 Million USD | -11.48% |
| 2017 Q3 | 24.92 Million USD | -6.08% |
| 2017 Q2 | 26.53 Million USD | 38.14% |
| 2016 Q4 | 22.68 Million USD | 11.27% |
| 2016 FY | 22.68 Million USD | 0.0% |
| 2016 Q3 | 20.38 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AbCellera Biologics Inc. | 335.77 Million USD | 23.468% |
| Alkermes plc | 933.53 Million USD | 72.473% |
| Agenus Inc. | 462.29 Million USD | 44.413% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | 93.656% |
| Aptorum Group Limited | 5.25 Million USD | -4788.507% |
| Ardelyx, Inc. | 130.76 Million USD | -96.52% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | 46.283% |
| Bicycle Therapeutics plc | 224.41 Million USD | -14.511% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -97.355% |
| ChromaDex Corporation | 26.5 Million USD | -869.428% |
| Chimerix, Inc. | 19.74 Million USD | -1201.474% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -630.52% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -254.122% |
| CRISPR Therapeutics AG | 346.76 Million USD | 25.894% |
| Precision BioSciences, Inc. | 140.92 Million USD | -82.356% |
| Dyadic International, Inc. | 2.34 Million USD | -10878.826% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -1480.127% |
| Fortress Biotech, Inc. | 165.93 Million USD | -54.862% |
| Lantern Pharma Inc. | 2.73 Million USD | -9279.775% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -259.508% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -7182.404% |
| Incyte Corporation | 1.59 Billion USD | 83.861% |
| IO Biotech, Inc. | 17.55 Million USD | -1363.75% |
| Jaguar Health, Inc. | 45.86 Million USD | -460.276% |
| Novavax, Inc. | 2.57 Billion USD | 90.01% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -612.674% |
| Opthea Limited | 264.6 Million USD | 2.882% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -96.605% |
| ContextLogic Inc. | 206 Million USD | -24.746% |
| MiMedx Group, Inc. | 96.33 Million USD | -166.766% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -435.121% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -7182.069% |
| NextCure, Inc. | 14.99 Million USD | -1613.516% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -6257.645% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -3748.675% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -449.811% |
| Vaxcyte, Inc. | 167.44 Million USD | -53.465% |
| PDS Biotechnology Corporation | 33.25 Million USD | -672.648% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -9.252% |
| Pharming Group N.V. | 244.07 Million USD | -5.287% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -2055.477% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -101.091% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -3789.286% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -3789.286% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -211.739% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -3768.373% |
| Acelyrin, Inc. | 86.35 Million USD | -197.588% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -19678.932% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -1687.162% |
| Summit Therapeutics Inc. | 125.25 Million USD | -105.159% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -2611.003% |
| Senti Biosciences, Inc. | 52.57 Million USD | -388.817% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -273.637% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -69.608% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -13037.832% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -19141.01% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -13.289% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -2643.418% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -12.984% |
| Sorrento Therapeutics, Inc. | 494.5 Million USD | 48.034% |
| TRACON Pharmaceuticals, Inc. | 10.91 Million USD | -2254.554% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -834.085% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -2022.944% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | 47.19% |
| Immix Biopharma, Inc. | 3.72 Million USD | -6804.648% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -579.615% |
| MEI Pharma, Inc. | 8.35 Million USD | -2975.715% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -785.666% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | 26.067% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -76.169% |
| Fortress Biotech, Inc. | 165.93 Million USD | -54.862% |
| Precigen, Inc. | 41.64 Million USD | -517.078% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -414.673% |
| AlloVir, Inc. | 45.01 Million USD | -470.867% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -97.163% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -86.485% |
| ImmuCell Corporation | 18.81 Million USD | -1265.802% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -810.423% |
| Onconetix, Inc. | 23.18 Million USD | -1008.568% |
| PureTech Health plc | 125.58 Million USD | -104.626% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -2771.24% |
| Elevation Oncology, Inc. | 34.28 Million USD | -649.595% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -10410.266% |
| Seer, Inc. | 39.36 Million USD | -552.803% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -315.59% |
| Innoviva, Inc. | 568.55 Million USD | 54.802% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -843.793% |
| ESSA Pharma Inc. | 3.49 Million USD | -7252.526% |
| GlycoMimetics, Inc. | 6.9 Million USD | -3623.171% |
| GT Biopharma, Inc. | 6.63 Million USD | -3774.205% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | 2.804% |
| Akebia Therapeutics, Inc. | 272.28 Million USD | 5.623% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -205.829% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -2529.179% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -845.843% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -7866.339% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -248.362% |
| Aptose Biosciences Inc. | 15.8 Million USD | -1525.535% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -2227.747% |
| Soligenix, Inc. | 7.27 Million USD | -3432.363% |
| Century Therapeutics, Inc. | 175.94 Million USD | -46.058% |
| Kura Oncology, Inc. | 51.66 Million USD | -397.418% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -111.883% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -6117.663% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -3785.419% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -1.733% |
| Autolus Therapeutics plc | 263.9 Million USD | 2.626% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -2351.593% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -189.189% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -447.935% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | 27.173% |
| GRI Bio, Inc. | 2.69 Million USD | -9428.217% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -31641.695% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -726.529% |
| IGM Biosciences, Inc. | 220.17 Million USD | -16.713% |
| INmune Bio, Inc. | 18.86 Million USD | -1262.401% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -0.194% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -864.559% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -9353.187% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -7733.999% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -339.613% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -167.241% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | 2.931% |
| Coherus BioSciences, Inc. | 823.02 Million USD | 68.777% |
| Verastem, Inc. | 71.18 Million USD | -260.997% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -422.564% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -566.121% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -425.17% |
| Histogen Inc. | 5.69 Million USD | -4410.725% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -5759.534% |
| Surrozen, Inc. | 8.14 Million USD | -3055.015% |
| Organovo Holdings, Inc. | 2.74 Million USD | -9251.383% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -81776.517% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -357.01% |
| Panbela Therapeutics, Inc. | 16.51 Million USD | -1456.298% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -402.859% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -30977.974% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -102.782% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -2276.417% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -70.308% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -9755.85% |
| Apollomics, Inc. | 14.15 Million USD | -1715.7% |
| Amarin Corporation plc | 279.58 Million USD | 8.087% |
| Mesoblast Limited | 188.79 Million USD | -36.112% |
| Turnstone Biologics Corp. | 14.14 Million USD | -1716.342% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -42.142% |
| Synaptogenix, Inc. | 5.52 Million USD | -4547.39% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -3765.463% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -51.066% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -2903.041% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -14522.569% |
| Exelixis, Inc. | 678.44 Million USD | 62.123% |
| Better Therapeutics, Inc. | 23.84 Million USD | -977.829% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -56.649% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | 56.753% |
| NLS Pharmaceutics AG | 10.68 Million USD | -2306.096% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -15727.388% |
| Aridis Pharmaceuticals, Inc. | 38.92 Million USD | -560.148% |
| Gritstone bio, Inc. | 125.91 Million USD | -104.08% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -1650.995% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -4950.007% |
| Avid Bioservices, Inc. | 275.66 Million USD | 6.781% |
| Insmed Incorporated | 1.66 Billion USD | 84.536% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -3239.943% |
| MediWound Ltd. | 27.18 Million USD | -845.216% |
| OmniAb, Inc. | 87.4 Million USD | -194.023% |
| Alector, Inc. | 487.66 Million USD | 47.305% |
| Seres Therapeutics, Inc. | 403.45 Million USD | 36.306% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -1294.714% |
| Viracta Therapeutics, Inc. | 38.37 Million USD | -569.679% |
| Zai Lab Limited | 240.17 Million USD | -6.994% |
| Revance Therapeutics, Inc. | 630.05 Million USD | 59.214% |
| Aura Biosciences, Inc. | 29.22 Million USD | -779.242% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -170.282% |
| Immunic, Inc. | 25.36 Million USD | -912.993% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -271.16% |
| Veracyte, Inc. | 93.71 Million USD | -174.198% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -9720.715% |
| FibroGen, Inc. | 585.72 Million USD | 56.127% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -1378.318% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -39248.56% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -4443.858% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 96.644% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -3034.618% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -205.844% |
| TG Therapeutics, Inc. | 169.08 Million USD | -51.98% |
| Galecto, Inc. | 5.89 Million USD | -4258.48% |
| Calithera Biosciences, Inc. | 8.28 Million USD | -3002.076% |
| Fortrea Holdings Inc. | 2.61 Billion USD | 90.186% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -791.597% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -1936.099% |
| XBiotech Inc. | 8.39 Million USD | -2960.331% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -1650.995% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -383.219% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | 29.228% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -855.87% |
| Theravance Biopharma, Inc. | 169 Million USD | -52.053% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | 78.86% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | 48.649% |
| Vaxxinity, Inc. | 30.94 Million USD | -730.455% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | 73.575% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -4160.843% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | 65.517% |
| NexImmune, Inc. | 5.08 Million USD | -4954.372% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -69092.286% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -8257.356% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 96.384% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -4885.924% |
| Scopus BioPharma Inc. | 7.45 Million USD | -3347.291% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -877.318% |
| Ainos, Inc. | 7.39 Million USD | -3375.362% |
| Pluri Inc. | 34.11 Million USD | -653.33% |
| Prothena Corporation plc | 135.01 Million USD | -90.329% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -5.707% |
| Celularity Inc. | 102.92 Million USD | -149.663% |
| Rallybio Corporation | 9.43 Million USD | -2623.357% |
| Cue Biopharma, Inc. | 24.44 Million USD | -951.242% |
| MeiraGTx Holdings plc | 319.99 Million USD | 19.693% |
| Omeros Corporation | 403.25 Million USD | 36.274% |
| Humacyte, Inc. | 114.67 Million USD | -124.087% |
| Immunocore Holdings plc | 228.15 Million USD | -12.631% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -5171.303% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -234.866% |
| Blueprint Medicines Corporation | 918.64 Million USD | 72.027% |
| CalciMedica, Inc. | 4.02 Million USD | -6279.742% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -1372.473% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -66.713% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -199.446% |
| Sana Biotechnology, Inc. | 277.79 Million USD | 7.494% |
| Pulmatrix, Inc. | 15.96 Million USD | -1509.823% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -1529.214% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -944.363% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -2.459% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -405.998% |
| Cytokinetics, Incorporated | 1.21 Billion USD | 78.774% |
| Eloxx Pharmaceuticals, Inc. | 31.78 Million USD | -708.533% |
| Nutriband Inc. | 1.07 Million USD | -23717.914% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -2316.778% |
| Vor Biopharma Inc. | 59.1 Million USD | -334.786% |
| Roivant Sciences Ltd. | 773.95 Million USD | 66.797% |
| Evogene Ltd. | 17.99 Million USD | -1328.438% |
| ProKidney Corp. | 29.21 Million USD | -779.573% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -257.015% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -36351.375% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | 86.396% |
| CorMedix Inc. | 11.91 Million USD | -2056.286% |
| BioLineRx Ltd. | 50.7 Million USD | -406.836% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -71.937% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -190.562% |
| Atai Life Sciences N.V. | 49.16 Million USD | -422.713% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -724.902% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -1330.665% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -106.181% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -4445.03% |
| MediciNova, Inc. | 3.89 Million USD | -6503.431% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -1305.854% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -16983.433% |
| GeoVax Labs, Inc. | 3.51 Million USD | -7200.701% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | 35.313% |
| Biomea Fusion, Inc. | 30.69 Million USD | -737.328% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | 90.558% |
| Mereo BioPharma Group plc | 15.96 Million USD | -1509.924% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -723.615% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -337.898% |
| Absci Corporation | 58.3 Million USD | -340.752% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -1249.097% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -701.497% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -248.253% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -193.744% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -660.959% |
| Allakos Inc. | 74.79 Million USD | -243.583% |
| Imunon, Inc. | 8.53 Million USD | -2912.464% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -1042.065% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -123.823% |
| BioAtla, Inc. | 48.98 Million USD | -424.591% |
| NLS Pharmaceutics AG | 10.68 Million USD | -2306.096% |
| Bio-Path Holdings, Inc. | 2.77 Million USD | -9147.067% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -96.76% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -1707.781% |
| XOMA Corporation | 145.58 Million USD | -76.519% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -663.333% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -273.734% |
| aTyr Pharma, Inc. | 31.59 Million USD | -713.292% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -315.664% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -471.502% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -430.92% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -8853.868% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -3049.981% |
| Akari Therapeutics, Plc | 4.58 Million USD | -5505.934% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -1349.129% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | 84.421% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -63522.409% |
| UroGen Pharma Ltd. | 243.52 Million USD | -5.524% |
| Sutro Biopharma, Inc. | 321.08 Million USD | 19.967% |
| ZIVO Bioscience, Inc. | 2.76 Million USD | -9205.472% |
| Orgenesis Inc. | 35.53 Million USD | -623.163% |
| Entera Bio Ltd. | 1.37 Million USD | -18534.953% |
| GH Research PLC | 6.7 Million USD | -3734.89% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -3679.059% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -1265.006% |
| Xencor, Inc. | 283.55 Million USD | 9.375% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -8506.965% |
| Replimune Group, Inc. | 113.21 Million USD | -126.983% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -6739.698% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -148.214% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -63522.409% |
| Portage Biotech Inc. | 4.45 Million USD | -5674.742% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -16983.433% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -1014.863% |
| OncoCyte Corporation | 49.29 Million USD | -421.271% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -6111.944% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -32123.342% |
| Purple Biotech Ltd. | 10 Million USD | -2468.476% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -4341.341% |
| scPharmaceuticals Inc. | 57.26 Million USD | -348.78% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -1974.391% |
| HilleVax, Inc. | 78.9 Million USD | -225.661% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -4988.634% |
| Tharimmune, Inc. | 1.81 Million USD | -14058.098% |
| Genprex, Inc. | 3.25 Million USD | -7796.729% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -847.587% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -4807.869% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -124645.631% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -71571.296% |
| OKYO Pharma Limited | 7.42 Million USD | -3362.894% |
| Savara Inc. | 37.19 Million USD | -590.944% |
| Curis, Inc. | 57.61 Million USD | -346.046% |
| Daré Bioscience, Inc. | 26.32 Million USD | -875.987% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -555.554% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -17696.122% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -1134.334% |
| BeiGene, Ltd. | 2.23 Billion USD | 88.496% |
| Kiromic BioPharma, Inc. | 21.28 Million USD | -1107.038% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | 2.066% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -1107.935% |
| Erasca, Inc. | 78.61 Million USD | -226.896% |
| bluebird bio, Inc. | 424.62 Million USD | 39.482% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -39117.889% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | 86.404% |
| DBV Technologies S.A. | 42.8 Million USD | -500.411% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -39117.889% |
| Moderna, Inc. | 4.57 Billion USD | 94.379% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -3573.71% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -15417.874% |
| Molecular Templates, Inc. | 31.17 Million USD | -724.407% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -1405.425% |
| Travere Therapeutics, Inc. | 588.1 Million USD | 56.304% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -106.398% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -836.604% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -604.894% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -361.896% |
| MacroGenics, Inc. | 154.2 Million USD | -66.644% |
| RenovoRx, Inc. | 4.46 Million USD | -5654.053% |
| Adicet Bio, Inc. | 37.12 Million USD | -592.284% |
| Prime Medicine, Inc. | 60.78 Million USD | -322.797% |
| Aditxt, Inc. | 28.53 Million USD | -800.673% |
| Adagene Inc. | 45.16 Million USD | -468.917% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -142110.613% |
| Quantum-Si incorporated | 26.63 Million USD | -864.951% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | 63.161% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -8346.384% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -123.533% |
| SciSparc Ltd. | 1.59 Million USD | -16011.348% |
| Vericel Corporation | 127.7 Million USD | -101.226% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -4517.806% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -201.056% |
| Generation Bio Co. | 171.63 Million USD | -49.727% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -2124.9% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -514.32% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -1.693% |
| Invivyd, Inc. | 51.71 Million USD | -396.927% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -179.392% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -3850.286% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -240.384% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -25069.05% |
| 2seventy bio, Inc. | 310.12 Million USD | 17.138% |
| ADMA Biologics, Inc. | 193.97 Million USD | -32.478% |
| Clene Inc. | 38.95 Million USD | -559.742% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -611.198% |
| GeoVax Labs, Inc. | 3.51 Million USD | -7200.701% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -35.064% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -2009.878% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -29.575% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -2007.259% |
| Finch Therapeutics Group, Inc. | 48.11 Million USD | -434.131% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -386.319% |
| Vir Biotechnology, Inc. | 369.85 Million USD | 30.52% |
| Evaxion Biotech A/S | 17.61 Million USD | -1358.642% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -59.683% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -67.754% |
| Trevena, Inc. | 48.26 Million USD | -432.46% |
| Surrozen, Inc. | 8.14 Million USD | -3055.015% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -1089.979% |
| Cingulate Inc. | 10.36 Million USD | -2380.256% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -9244.582% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -589.091% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -7065.051% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -1854.19% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | 18.986% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -934.15% |
| Clearmind Medicine Inc. | 3.61 Million USD | -7018.433% |
| Kronos Bio, Inc. | 54.2 Million USD | -374.117% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -446.258% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -1029.082% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -1180.335% |
| Statera Biopharma, Inc. | 22.67 Million USD | -1033.228% |
| ImmunityBio, Inc. | 1.09 Billion USD | 76.433% |
| Korro Bio, Inc. | 51.75 Million USD | -396.553% |
| Kineta, Inc. | 7.22 Million USD | -3458.239% |
| BioVie Inc. | 9.7 Million USD | -2548.656% |
| Codexis, Inc. | 49.94 Million USD | -414.508% |
| Celularity Inc. | 102.92 Million USD | -149.663% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -166.996% |
| Celcuity Inc. | 51.45 Million USD | -399.467% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -74343.936% |
| Cibus, Inc. | 206.11 Million USD | -24.675% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -505.005% |
| eFFECTOR Therapeutics, Inc. | 26.33 Million USD | -875.648% |
| IN8bio, Inc. | 8.77 Million USD | -2829.503% |
| Kodiak Sciences Inc. | 213.59 Million USD | -20.312% |
| Annexon, Inc. | 47.11 Million USD | -445.388% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -186.993% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -166.65% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -1777.245% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | 90.129% |
| Eyenovia, Inc. | 19.78 Million USD | -1199.152% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -45.114% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -3245.606% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -966.335% |
| Arcellx, Inc. | 339.75 Million USD | 24.364% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -2059.825% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -4.657% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -2587.19% |
| Moolec Science SA | 13.94 Million USD | -1742.735% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -495.514% |
| Geron Corporation | 146.12 Million USD | -75.858% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -408.541% |
| Royalty Pharma plc | 6.29 Billion USD | 95.919% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -546.058% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -87186.265% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -10344.982% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -35.854% |
| Humacyte, Inc. | 114.67 Million USD | -124.087% |
| Structure Therapeutics Inc. | 29.05 Million USD | -784.568% |
| 89bio, Inc. | 59.96 Million USD | -328.558% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -871.077% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -21386.288% |
| Genelux Corporation | 8.42 Million USD | -2951.971% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -3648.191% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -88.511% |
| Notable Labs, Ltd. | 4.42 Million USD | -5704.744% |
| Liquidia Corporation | 73.13 Million USD | -251.358% |
| Mustang Bio, Inc. | 17.61 Million USD | -1358.516% |
| Immunovant, Inc. | 48.95 Million USD | -424.923% |
| Quantum-Si incorporated | 26.63 Million USD | -864.951% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -569.505% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -8181.534% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -247.918% |
| Acasti Pharma Inc. | 11.55 Million USD | -2123.553% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -1036.673% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -9353.187% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -596.846% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -18755.891% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -4115.486% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -934.733% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -1008.42% |
| PepGen Inc. | 34.63 Million USD | -642.04% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -2016.074% |
| United Therapeutics Corporation | 1.18 Billion USD | 78.263% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -3579.496% |
| Solid Biosciences Inc. | 38.45 Million USD | -568.199% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -2903.041% |
| Immuneering Corporation | 12 Million USD | -2039.977% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -81776.517% |
| Silo Pharma, Inc. | 1.56 Million USD | -16275.512% |
| Belite Bio, Inc | 4.21 Million USD | -6002.493% |
| XOMA Corporation | 145.58 Million USD | -76.519% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -10483.855% |
| Bionomics Limited | 10.15 Million USD | -2429.61% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -1095.738% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -1021.529% |
| uniQure N.V. | 624.01 Million USD | 58.819% |
| Cassava Sciences, Inc. | 14.19 Million USD | -1710.328% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -142110.613% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -50.999% |
| Forte Biosciences, Inc. | 3.66 Million USD | -6909.711% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -98515.796% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -3708.745% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -3245.606% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -1378.318% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -2331.643% |
| Altimmune, Inc. | 16.54 Million USD | -1453.57% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | 58.398% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -1021.529% |
| Compugen Ltd. | 55.77 Million USD | -360.737% |
| Peak Bio, Inc. | 20.75 Million USD | -1138.238% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -132.635% |
| Benitec Biopharma Inc. | 4.96 Million USD | -5078.879% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -62.805% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -241.842% |
| Zura Bio Limited | 21.29 Million USD | -1106.913% |
| PolyPid Ltd. | 17.46 Million USD | -1371.124% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -128.628% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -241.842% |
| Instil Bio, Inc. | 99.8 Million USD | -157.488% |
| argenx SE | 444.95 Million USD | 42.246% |
| Immunome, Inc. | 28.65 Million USD | -796.699% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -2982.356% |
| Verona Pharma plc | 58.84 Million USD | -336.729% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -1675.554% |
| Shattuck Labs, Inc. | 14.85 Million USD | -1629.43% |
| CervoMed Inc. | 2.59 Million USD | -9799.886% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -5172.384% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -1917.714% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -2339.26% |
| Moolec Science SA | 13.94 Million USD | -1742.735% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -10865.46% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -362.226% |
| AnaptysBio, Inc. | 364.28 Million USD | 29.458% |
| Design Therapeutics, Inc. | 11.95 Million USD | -2049.348% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -1925.985% |
| NeurAxis, Inc. | 1.91 Million USD | -13334.975% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -560.132% |
| Lumos Pharma, Inc. | 13.33 Million USD | -1827.368% |
| Achilles Therapeutics plc | 19.08 Million USD | -1246.34% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -1675.554% |
| 180 Life Sciences Corp. | 5.38 Million USD | -4670.114% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -989.436% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -1029.082% |
| Nutriband Inc. | 1.07 Million USD | -23717.914% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -739.846% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -1670.905% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | 35.96% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -691.353% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -1869.301% |
| Palisade Bio, Inc. | 2.73 Million USD | -9282.11% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -4791.986% |
| Beam Therapeutics Inc. | 478.38 Million USD | 46.283% |
| Neurogene Inc. | 36.54 Million USD | -603.1% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | 35.425% |
| AEON Biopharma, Inc. | 159.88 Million USD | -60.722% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -439.299% |
| Sesen Bio, Inc. | 30.98 Million USD | -729.383% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -889.854% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -3280.278% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -31.286% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -33.802% |
| Athira Pharma, Inc. | 30.05 Million USD | -754.962% |
| Vaccinex, Inc. | 5.94 Million USD | -4224.739% |
| HCW Biologics Inc. | 15.05 Million USD | -1607.261% |
| XOMA Corporation | 145.58 Million USD | -76.519% |
| Nektar Therapeutics | 267.04 Million USD | 3.771% |
| Arvinas, Inc. | 644.6 Million USD | 60.134% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -1349.129% |
| Merus N.V. | 102.15 Million USD | -151.565% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -75.59% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -170.16% |
| Rezolute, Inc. | 11.73 Million USD | -2090.012% |
| Clene Inc. | 38.95 Million USD | -559.742% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -8924.998% |
| BeyondSpring Inc. | 48.26 Million USD | -432.383% |
| Synlogic, Inc. | 32.89 Million USD | -681.201% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -1658.544% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -15626.805% |
| Peak Bio, Inc. | 20.75 Million USD | -1138.238% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -304.948% |
| Krystal Biotech, Inc. | 39.71 Million USD | -547.067% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | 31.772% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -158.088% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -59285.385% |
| MannKind Corporation | 721.36 Million USD | 64.376% |
| Ikena Oncology, Inc. | 22.33 Million USD | -1050.553% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -12219.08% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -150.488% |
| Gossamer Bio, Inc. | 249.14 Million USD | -3.142% |
| CohBar, Inc. | 1.03 Million USD | -24761.315% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -2304.116% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -1249.097% |
| Legend Biotech Corporation | 589.93 Million USD | 56.44% |
| Mural Oncology plc | 37.92 Million USD | -577.536% |
| Biora Therapeutics, Inc. | 132.63 Million USD | -93.745% |
| PaxMedica, Inc. Common Stock | 2.29 Million USD | -11095.592% |
| Disc Medicine, Inc. | 22.87 Million USD | -1023.392% |
| Champions Oncology, Inc. | 28.03 Million USD | -816.626% |
| REGENXBIO Inc. | 262.22 Million USD | 2.003% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -7549.571% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -1950.231% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -1813.216% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -1111.865% |
| Vaxart, Inc. | 34.02 Million USD | -655.256% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -1160.35% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -800.663% |
| Cellectis S.A. | 249.57 Million USD | -2.965% |
| Longeveron Inc. | 5.33 Million USD | -4714.99% |
| Repare Therapeutics Inc. | 41.81 Million USD | -514.496% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | 89.316% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -325.682% |
| Revolution Medicines, Inc. | 262.39 Million USD | 2.066% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -12096.298% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -2879.086% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -2077.578% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -1729.922% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -11846.815% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 95.01% |
| Denali Therapeutics Inc. | 122.96 Million USD | -108.986% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -4517.806% |
| Veru Inc. | 32.81 Million USD | -683.16% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -3641.098% |
| Cingulate Inc. | 10.36 Million USD | -2380.256% |
| Passage Bio, Inc. | 39.26 Million USD | -554.516% |
| Context Therapeutics Inc. | 4.19 Million USD | -6030.569% |
| Exicure, Inc. | 8.54 Million USD | -2905.919% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -770.869% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -2350.658% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -1065.9% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -57.668% |
| Nuvalent, Inc. | 31.82 Million USD | -707.517% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -3939.47% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -307.756% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -1327.644% |
| OmniAb, Inc. | 87.4 Million USD | -194.023% |
| Anew Medical, Inc. | 8.24 Million USD | -3017.96% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -571.147% |
| Lipocine Inc. | 2.63 Million USD | -9664.902% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -878.136% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -539.053% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -864.559% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -198.275% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -4657.934% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -210.556% |
| Ocugen, Inc. | 23.98 Million USD | -971.492% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -453.744% |
| Q32 Bio Inc. | 233.12 Million USD | -10.23% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -2734.503% |
| Alumis Inc. Common Stock | 53.5 Million USD | -380.311% |
| Equillium, Inc. | 27.95 Million USD | -819.183% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -24.388% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -4467.11% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -4090.076% |
| Galera Therapeutics, Inc. | 157.32 Million USD | -63.34% |
| Evelo Biosciences, Inc. | 69.43 Million USD | -270.106% |
| Comera Life Sciences Holdings, Inc. | 9.97 Million USD | -2476.407% |
| Dominari Holdings Inc. | 4.63 Million USD | -5444.25% |
| Edesa Biotech, Inc. | 1.84 Million USD | -13853.673% |
| vTv Therapeutics Inc. | 29.56 Million USD | -769.131% |
| Bio-Techne Corporation | 744.34 Million USD | 65.476% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -103.789% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | 25.397% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -533.336% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -787.44% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -178.233% |
| Nkarta, Inc. | 105.6 Million USD | -143.348% |
| BioCardia, Inc. | 4.59 Million USD | -5498.606% |
| Iterum Therapeutics plc | 32.66 Million USD | -686.774% |